NKTR Nektar Therapeutics
Healthcare$65.56-1.58%ClosedMarket Cap: $1.28B
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
0
Dispositions
2
Buy/Sell Ratio
0.00
Net Shares
-643
Shares Acquired
0
Shares Disposed
643
Total Bought ($)
$0.00
Total Sold ($)
$2.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu May 21 | Zalevsky Jonathan | officer: Chief R&D Officer | Sell | 199 | $65.51 | 20,975 |
| Thu May 21 | ROBIN HOWARD W | director, officer: President & CEO | Sell | 444 | $65.51 | 75,045 |
| Fri Feb 20 | Zalevsky Jonathan | officer: Chief R&D Officer | Sell | 180 | $73.00 | 21,174 |
| Fri Feb 20 | ROBIN HOWARD W | director, officer: President & CEO | Sell | 423 | $73.00 | 75,489 |
| Thu Jan 22 | Zalevsky Jonathan | officer: Chief R&D Officer | Sell | 3,867 | $35.67 | 21,354 |
| Tue Dec 23 | Zalevsky Jonathan | officer: Chief R&D Officer | Sell | 25,000 | $43.48 | 25,000 |
| Tue Dec 23 | Zalevsky Jonathan | officer: Chief R&D Officer | Sell | 6,250 | $0.00 | 25,221 |
| Tue Dec 23 | ROBIN HOWARD W | director, officer: President & CEO | Sell | 86,667 | $43.48 | 86,667 |
| Tue Dec 23 | ROBIN HOWARD W | director, officer: President & CEO | Sell | 21,667 | $0.00 | 75,912 |
| Tue Nov 25 | Zalevsky Jonathan | officer: Chief R&D Officer | Sell | 1,157 | $54.28 | 18,971 |
| Tue Nov 25 | Zalevsky Jonathan | officer: Chief R&D Officer | Sell | 4,766 | $281.25 | 4,766 |
| Tue Nov 25 | Zalevsky Jonathan | officer: Chief R&D Officer | Sell | 2,666 | $0.00 | 20,128 |